Ositag Tablet 80 mg contains Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is an oral targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. Osimertinib is designed to inhibit cancer cell growth while offering improved selectivity and effectiveness compared to earlier EGFR inhibitors.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Osimertinib
• Strength: 80 mg per tablet

Mechanism of Action

Osimertinib selectively and irreversibly inhibits mutated forms of the EGFR tyrosine kinase, including T790M resistance mutations. By blocking EGFR signaling pathways, it prevents cancer cell proliferation, reduces tumor growth, and promotes cancer cell death while having reduced activity against normal EGFR in healthy tissues.

Indications

Ositag Tablet 80 mg is indicated for:

• First-line treatment of EGFR mutation-positive metastatic non-small cell lung cancer (NSCLC)
• Treatment of NSCLC with T790M resistance mutation after progression on other EGFR TKIs
• Adjuvant treatment in early-stage EGFR-mutated NSCLC (as prescribed by oncologist)

Dosage and Administration

• Taken orally once daily or as directed by an oncologist
• Should be taken at the same time each day
• Can be taken with or without food
• Tablets should be swallowed whole with water
• Treatment continues until disease progression or unacceptable toxicity

Benefits

• Targeted therapy for EGFR-mutated lung cancer
• Effective against resistance mutation (T790M)
• Improves progression-free survival
• Oral administration for patient convenience
• Better central nervous system penetration for brain metastases

Possible Side Effects

Common side effects may include:

• Diarrhea
• Rash or dry skin
• Nail changes
• Fatigue
• Decreased appetite

Serious side effects may include interstitial lung disease (ILD), cardiac effects, and QT prolongation. Regular monitoring is essential.

Precautions and Warnings

• Must be used under strict oncology supervision
• Regular lung, liver, and cardiac monitoring is required
• Not recommended during pregnancy or breastfeeding
• Use caution in patients with pre-existing lung disease
• Inform your doctor about all ongoing medications

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store in a cool and dry place
• Protect from light and moisture
• Keep out of reach of children

Conclusion

Ositag Tablet 80 mg (Osimertinib) is an advanced targeted therapy for EGFR-mutated non-small cell lung cancer. It offers effective disease control and improved outcomes when used under specialist supervision as part of a comprehensive oncology treatment plan.